Question 1

Who owns BCLI?

Accepted Answer

BRAINSTORM CELL THERAPEUTICS (BCLI) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Question 2

Are institutions buying or selling BCLI?

Accepted Answer

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for BRAINSTORM CELL THERAPEUTICS, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

Question 3

What is the Smart Money Verdict on BCLI?

Accepted Answer

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for BRAINSTORM CELL THERAPEUTICS.

Question 4

Is institutional money flowing into BCLI?

Accepted Answer

0 institutional investors hold BRAINSTORM CELL THERAPEUTICS (BCLI). View detailed buyer/seller breakdown on HoldingsIntel.

Question 5

What do hedge funds think about BCLI?

Accepted Answer

Track institutional sentiment and conviction scores for BRAINSTORM CELL THERAPEUTICS (BCLI) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
OSAIC HOLDINGS, INC.	Exited	0(-100.0%)	$1,351	0.0%	-99.58%	0
Steward Partners Investment Advisory, LLC	Exited	0(-100.0%)	$80	0.0%	-99.22%	0

BRAINSTORM CELL THERAPEUTICS

Continue exploring